滚动资讯
FierceBiotechDefinium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO saysFierceBiotechHelmed by Sanofi vet, Bionyara emerges with $165M and three licensed I&I assetsEndpoints NewsRegenxbio to resubmit Hunter syndrome gene therapy without new studyEndpoints NewsDefinium reports Phase 3 hit for LSD drug in severe form of depressionEndpoints NewsAbbVie makes $10.9B move for Apogee's long-acting I&I drug candidatesEndpoints NewsA Sanofi alum looks to take on the TL1A field with $165M for BionyraBioPharma DiveBionyra brings in $165M for next-generation immune drugsEndpoints News赛诺菲研发负责人侯曼·阿什拉菲安将离职，保罗·丰图拉接任FierceBiotech赛诺菲研发负责人Ashrafian即将离职，新任CEO欲携罗氏老将重振低迷研发管线Endpoints NewsNura Bio获7380万美元推进SARM1抑制剂治疗神经退行性疾病BioPharma Dive前14天：特色项目如何助患者迈向成功之路BioPharma Dive从片段到终生：人工智能如何助力女性健康品牌建立持久合作

资讯库

最新 最旧
总数 13640
页码 107 / 758
搜索 --